Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Little elongation complex subunit 1 (ICE1) is a large (~250 kDa) nuclear protein that functions as a critical scaffold component of the little elongation complex (LEC), a multi-protein complex essential for the regulation of small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III[1][2][3][4]. ICE1 enables the assembly and stability of the LEC, thereby contributing to the accurate elongation of snRNA transcripts and facilitating proper recruitment of RNA polymerase II at snRNA gene promoters[1][5][7]. Beyond its role in snRNA biogenesis, ICE1 also participates in RNA surveillance mechanisms, specifically by promoting the link between splicing and nonsense-mediated mRNA decay (NMD) through a conserved C-terminal MIF4G domain[2][3][4]. ICE1 interacts transiently with the exon junction complex (EJC), and its depletion disrupts the association between the NMD factor UPF3B and the EJC, impairing NMD efficiency[2][3][4]. Diseases associated with ICE1 include Cri-du-chat syndrome and Tinea nigra, and its locus in human genetic studies implicates it in neurodevelopment via snRNA processing[1][3]. ICE1 does not have well-characterized direct interactions with drugs, nor is it a typical therapeutic target such as a receptor, enzyme, or transporter[1][3][5]. Overall, ICE1 is a context-dependent, evolutionarily conserved regulator of non-coding RNA transcription and RNA metabolism, acting primarily as a structural and regulatory scaffold in its complexes rather than as an enzyme or classical drug target[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Little elongation complex subunit 1 (ICE1).